Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-31

Clinical Trial Update: Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update on rivaroxaban as chemoprophylaxis for lower limb deep vein thrombosis in patients with colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Hospital do Servidor Publico Estadual | Conditions: Deep Venous Thrombosis, Colonic Cancer | Phase 4 | Status: UNKNOWN